Non-Invasive Prenatal Testing Market is expected to generate a revenue of USD 9.83 Billion by 2031, Globally, at 17.01% CAGR: Verified Market Research®

GlobeNewswire Inc. • Jan 9, 2026 10:53am (New York) •By Verified Market Research

Non-Invasive Prenatal Testing Market is expected to generate a revenue of USD 9.83 Billion by 2031, Globally, at 17.01% CAGR: Verified Market Research®

The global Non-Invasive Prenatal Testing (NIPT) market is projected to grow at a CAGR of 17.01% from 2024 to 2031, reaching USD 9.83 billion from USD 2.8 billion in 2024. Growth is driven by rising demand for early fetal detection, advancements in next-generation sequencing technology, and increased adoption of safer prenatal testing methods. However, high costs, regulatory hurdles, and limited insurance coverage remain significant market restraints, particularly in emerging markets.

← Back to news Read Original Article

Insights

NTRA positive

Listed as a major player in the rapidly growing NIPT market with strong projected growth of 17.01% CAGR through 2031, indicating significant market expansion opportunities.

Keywords

#Non-Invasive Prenatal Testing #NIPT market #next-generation sequencing #prenatal care #genomic technology #fetal abnormality detection #market growth #healthcare technology

Tickers

NTRA ILMN RHHBY DGX

← Prev: SPAC Merger To Take SL Bio Public Through New Entity In 2026

Next: Military Antenna Market is expected to generate a revenue of USD 6.56 Billion by 2032, Globally, at 5.56% CAGR: Verified Market Research® →